A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies

被引:29
|
作者
Muses, Sofia [1 ]
Morgan, Jennifer E. [2 ]
Wells, Dominic J. [1 ]
机构
[1] Univ London Royal Vet Coll, London, England
[2] UCL Inst Child Hlth, London, England
来源
PLOS ONE | 2011年 / 6卷 / 09期
基金
英国惠康基金;
关键词
SLEEPING-BEAUTY; SKELETAL-MUSCLE; GENE-TRANSFER; STEM-CELL; SATELLITE CELLS; SELF-RENEWAL; MOUSE MUSCLE; TRANSPOSON; EXPRESSION; MDX;
D O I
10.1371/journal.pone.0024826
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2K(b)-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks, without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for muscle disease.
引用
收藏
页数:11
相关论文
共 11 条
  • [11] The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients: the challenge is open for new therapeutic strategies
    Ferro, Alessandra
    Marinato, Gian Marco
    Mulargiu, Cristiana
    Marino, Monica
    Pasello, Giulia
    Guarneri, Valentina
    Bonanno, Laura
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 196